A fermentation process for the production of P50 from Serratia marcescens
暂无分享,去创建一个
P. Aguilar | A. Musacchio | V. Lugo | J. Valdés | M. C. Abrahantes | R. Espinosa | Marta Pupo | Maelys Millares | Inalvis Herrera | Danae Arias
[1] Takashi Shimizu,et al. Serratia marcescens Serralysin Induces Inflammatory Responses through Protease-Activated Receptor 2 , 2006, Infection and Immunity.
[2] V. Huerta,et al. Cytotoxic Proteins Combined with Prodigiosin Obtained from Serratia marcescens Have Both Broad and Selective Cytotoxic Activity on Tumor Cells , 2006, Journal of chemotherapy.
[3] G V Carbonell,et al. Biological activity of Serratia marcescens cytotoxin. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[4] S. Blanke,et al. Characterization of a Cytotoxic Factor in Culture Filtrates of Serratia marcescens , 2002, Infection and Immunity.
[5] W. Siqueira,et al. Cytotoxin production in phytopathogenic and entomopathogenic Serratia marcescens. , 2001, Revista latinoamericana de microbiologia.
[6] H. Maeda,et al. Enhanced Vascular Permeability in Solid Tumor Involving Peroxynitrite and Matrix Metalloproteinases , 2001, Japanese journal of cancer research : Gann.
[7] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[8] T. Pitt,et al. Antibiotic resistance and putative virulence factors of Serratia marcescens with respect to O and K serotypes. , 1998, Journal of medical microbiology.
[9] A. Hejazi,et al. The use of RAPD-PCR as a typing method for Serratia marcescens. , 1997, Journal of medical microbiology.
[10] A. Musacchio,et al. Recombinant Opc meningococcal protein, folded in vitro, elicits bactericidal antibodies after immunization. , 1997, Vaccine.
[11] H. Maeda. Role of Microbial Proteases in Pathogenesis , 1996, Microbiology and immunology.
[12] T. Zor,et al. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. , 1996, Analytical biochemistry.
[13] M. Yap,et al. Formulation and optimization of two culture media for the production of tumour necrosis factor-β in Escherichia coli , 1995 .
[14] H. Maeda,et al. Pathogenic potentials of bacterial proteases. , 1989, Clinica chimica acta; international journal of clinical chemistry.
[15] G. Ihler,et al. Genetic analysis of extracellular proteins of Serratia marcescens , 1988, Journal of bacteriology.
[16] H. Maeda,et al. The serratial 56K protease as a major pathogenic factor in serratial keratitis. Clinical and experimental study. , 1985, Ophthalmology.
[17] R. M. Joyce. Experiment optimization in chemistry and chemical engineering, S. Akhnazarova and V. Kafarov, Mir Publishers, Moscow and Chicago, 1982, 312 pp. Price: $9.95. , 1984 .
[18] V L Yu,et al. Serratia marcescens: historical perspective and clinical review. , 1979 .
[19] B. D. da Fonseca,et al. Morphological and intracellular alterations induced by Serratia marcescens cytotoxin. , 2004, Research in microbiology.
[20] A. I. Khuri,et al. Response Surfaces: Designs and Analyses: Second Edition , 1987 .
[21] H. Maeda,et al. Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease. , 1984, Journal of biochemistry.
[22] U. K. Laemmli,et al. Cleavage of structural proteins during , 1970 .